STAT1 and Miyoshi myopathy: Target engagement and Mediator kinase inhibition by CCT251545 in MM SCs was confirmed by analysis of INFγ-stimulated STAT1 phosphorylation on serine residue 727 (pSTAT1SER727), a validated biomarker of Mediator kinase activity in vivo [28, 30].